FDA Approves Abbott's Updated CardioMEMS HF System

Abbott (NYSE: ABT) has received FDA approval for updates to its CardioMEMS HF System, which now includes the CardioGuide HF App. This update allows U.S. CardioMEMS patients to view their pulmonary artery pressure (PAP) readings directly on their smartphones, enhancing patient engagement in their healthcare management.